Hipereosinofilia segunda parte

Link de acceso a ppt: Hipereosinofilia segunda parte

Artículos de interés:


1) World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management. 

2) A Tyrosine Kinase Created by Fusion of the  PDGFRA  and  FIP1L1  Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome.

3)  Hypereosinophilic syndromes: a multicenter, retrospective analysis of clinical characteristics and response to therapy